Alnylam Pharmaceuticals
ALNY
ALNY
518 hedge funds and large institutions have $29.1B invested in Alnylam Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 87 funds opening new positions, 194 increasing their positions, 164 reducing their positions, and 57 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
518
Holders Change
+23
Holders Change %
+4.65%
% of All Funds
7.53%
Holding in Top 10
6
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-25%
% of All Funds
0.09%
New
87
Increased
194
Reduced
164
Closed
57
Calls
$703M
Puts
$600M
Net Calls
+$103M
Net Calls Change
-$53.2M
Top Buyers
| 1 |
1
Fidelity Investments
Boston,
Massachusetts
|
$2.96B |
| 2 |
2
Capital World Investors
Los Angeles,
California
|
$3.64B |
| 3 |
OAG
3
Orbis Allan Gray
Hamilton,
Bermuda
|
$175M |
| 4 |
4
BlackRock
New York
|
$2.32B |
| 5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$3.04B |
